Osprey Medical
  • Technology
    • DyeVert™ PLUS EZ
    • DyeVert™ PLUS
  • Be Kind to Kidneys™
  • Patients
    • About Your Kidneys
    • Patients at Risk
    • Kidney Kindness in the Cath Lab
    • Martha’s Story
    • DyeVert™ Plus System
  • International
    • DyeVert™ PLUS EZ
    • DyeVert™ Power XT
    • Instructions for Use – International
  • About Us
    • Management
    • Board of Directors
    • News
    • Patents
  • Investors
    • Financial Information
    • Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Contact Us
  • Search
  • Menu

Investors

  • Financial Information
  • Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Contact Us

Osprey Medical is
dedicated to making
angiography safer
for chronic kidney
disease patients.

Osprey Medical designs, develops, and manufactures proprietary devices and monitoring systems that reduce the amount of X-ray dye (contrast) used during commonly performed heart imaging procedures.

Our Mission

To improve outcomes in patients suffering from Chronic Kidney Disease (CKD) by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs.

35%

Revenue growth*

36%

Unit growth*

*Q4 ’18 vs. Q4 ’19

In the News

Supplier Horizon Award

Osprey receives Supplier Horizon Award from Premier Inc

September 29, 2020
Osprey Medical has been selected as a Supplier Horizon Award recipient by Premier Inc., one of nine suppliers to win the prestigious award, and is the only cardiovascular supplier to receive the award this year.
Read more
https://ospreymed.com/wp-content/uploads/2020/10/Supplier-Horizon-Award.jpg 600 600 Cat Gilfillen /wp-content/uploads/2017/04/osprey-logo-224w.png Cat Gilfillen2020-09-29 01:08:262020-10-01 01:08:51Osprey receives Supplier Horizon Award from Premier Inc
DyeVert Logo

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

July 30, 2020
Osprey Medical (ASX: OSP) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).
Read more
https://ospreymed.com/wp-content/uploads/2020/09/DyeVert_Logo-4C.jpg 700 700 Cat Gilfillen /wp-content/uploads/2017/04/osprey-logo-224w.png Cat Gilfillen2020-07-30 20:40:492020-09-30 20:42:01GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

All Osprey Medical News

Osprey Medical’s product specific labeling indications may vary by geography.

© 2020 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, and Be Kind to Kidneys are registered Trademarks of Osprey Medical, Inc. in the United States and other countries.
  • Contact
  • Resources
  • Privacy
  • Terms of Use

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.

Scroll to top